Nano-Oncology: Clinical Application for Cancer Therapy and Future Perspectives

<table class="table-group" id="tab6"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left"> </td><td align="center">Neuropathy (%)</td><td align="center">Alopecia (%)</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">Conventional daunorubicin</td><td align="center">41</td><td align="center">36</td></tr><tr><td align="left">DaunoXome</td><td align="center">13</td><td align="center">8</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Comparative toxicity (neuropathy and alopecia) of DaunoXomeand free daunorubicine. 

Journal of Nanomaterials

tab6

Table 6

Table 6: Nano-Oncology: Clinical Application for Cancer Therapy and Future Perspectives 